Get the Stockscreener App
1.53
5.56%
-0.09
After Hours:
1.55
0.02
+1.31%
TRACON Pharmaceuticals Inc Stock (TCON) Forecast
The TRACON Pharmaceuticals Inc (TCON) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.2534, representing a +47.28% increase from the current price of $1.53. The highest analyst price target is $3.8088, and the lowest is $0.698.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TCON Price Target
Average 1.9235
(+25.72% Upside)
Is TRACON Pharmaceuticals Inc (TCON) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.80 | Neutral |
| STOCH(9,6) | 48.13 | Neutral |
| STOCHRSI(14) | 70.18 | Neutral |
| MACD(12,26) | 0.1244 | Sell |
| ADX(14) | 33.84 | Buy |
| William %R | -97.44 | Buy |
| CCI(14) | -174.52 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.815
Sell
|
1.7786
Sell
|
| MA20 |
1.8197
Sell
|
1.7303
Sell
|
| MA50 |
1.2108
Buy
|
1.3413
Buy
|
| MA100 |
0.6966
Buy
|
0.953
Buy
|
| MA200 |
0.4529
Buy
|
0.7866
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, TCON could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 6 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on TCON, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 46.8 indicates that TCON is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 48.13 indicates that TCON is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 70.18 indicates that TCON is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.84 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -174.52 indicates that TCON is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term TCON price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about TRACON Pharmaceuticals Inc financial reports and earnings history, TRACON Pharmaceuticals Inc (TCON) stock could reach $3.5354 by 2030, $4.4837 by 2040 and $12.53 by 2050. See the projected annual prices until 2050 of the TRACON Pharmaceuticals Inc stock below:
- TRACON Pharmaceuticals Inc (TCON) is expected to reach an average price of $3.1232 in 2035, with a high prediction of $3.2425 and a low estimate of $3.1505. This indicates an $104.13% rise from the last recorded price of $1.53.
- TRACON Pharmaceuticals Inc (TCON) stock is projected to chart a bullish course in 2040, with an average price target of $5.5347, representing an $261.75% surge from its current level. The forecast ranges from a conservative $4.5433 to a sky-high $4.4837.
- Our analysts predict TRACON Pharmaceuticals Inc (TCON) to jump 450.45% by 2045, soaring from $8.5009 to an average price of $8.4218, potentially reaching $8.3819. While $8.5009 is the low estimate, the potential upside is significant.
- TRACON Pharmaceuticals Inc (TCON) stock is expected to climb by 2050, reaching an average of $12.34, a $706.21% jump from its current level. However, a wide range of estimates exists, with high and low targets of $12.53 and $12.67, respectively, highlighting the market's uncertainty.
TRACON Pharmaceuticals Inc Stock (TCON) Year by Year Forecast
TRACON Pharmaceuticals Inc Stock (TCON) Price Forecast for 2024
Our forecast for TCON stock price in 2024 now indicates an average price target of $1.9235 with a high forecast of $3.8088 and a low forecast of $0.0382. The average prediction reflects an increase of +25.72% from the last recorded price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.8598 | $0.698 | $3.8088 | +21.56% |
| July, 2024 | $0.5249 | $0.0382 | $1.7751 | -65.69% |
| August, 2024 | $0.2141 | $0.5116 | $0.6099 | -86.00% |
| September, 2024 | $0.2828 | $0.0596 | $1.1414 | -81.52% |
| October, 2024 | $1.3415 | $0.4056 | $1.0545 | -12.32% |
| November, 2024 | $1.0395 | $0.9227 | $1.0743 | -32.06% |
| December, 2024 | $1.5865 | $1.4997 | $1.1465 | +3.69% |
TRACON Pharmaceuticals Inc Stock (TCON) Price Forecast for 2025
TRACON Pharmaceuticals Inc Stock (TCON) is expected to reach an average price of $1.6238 in 2025, with a high prediction of $3.2243 and a low estimate of $0.0233. This indicates an +6.13% rise from the last recorded price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.2202 | $2.2332 | $2.3434 | +45.11% |
| February, 2025 | $0.6271 | $0.9471 | $1.6169 | -59.01% |
| March, 2025 | $1.6228 | $0.6405 | $0.8481 | +6.06% |
| April, 2025 | $2.8778 | $2.1008 | $3.2243 | +88.09% |
| May, 2025 | $2.2748 | $2.2948 | $2.7945 | +48.68% |
| June, 2025 | $2.3817 | $2.6417 | $2.4782 | +55.67% |
| July, 2025 | $2.3354 | $2.3619 | $2.3385 | +52.64% |
| August, 2025 | $2.3824 | $2.3589 | $2.3126 | +55.71% |
| September, 2025 | $2.3594 | $2.4291 | $2.4226 | +54.21% |
| October, 2025 | $1.0631 | $2.1831 | $2.3596 | -30.52% |
| November, 2025 | $1.06 | $0.0233 | $2.2335 | -30.72% |
| December, 2025 | $0.5963 | $0.263 | $1.8498 | -61.03% |
TRACON Pharmaceuticals Inc Stock (TCON) Price Forecast for 2026
The predicted value for TRACON Pharmaceuticals Inc (TCON) in 2026 is set at an average of $4.156. Estimates vary from a peak of $8.3021 to a trough of $0.0099, indicating an +171.63% surge from the present price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.8393 | $0.5121 | $6.1173 | +216.29% |
| February, 2026 | $3.8723 | $3.3491 | $6.6726 | +153.09% |
| March, 2026 | $6.2854 | $3.5256 | $8.3021 | +310.81% |
| April, 2026 | $7.0917 | $4.7219 | $7.9417 | +363.51% |
| May, 2026 | $5.8847 | $3.0182 | $7.1049 | +284.62% |
| June, 2026 | $4.9078 | $3.4316 | $5.998 | +220.77% |
| July, 2026 | $2.514 | $1.7957 | $4.831 | +64.32% |
| August, 2026 | $2.9271 | $1.9816 | $3.3526 | +91.31% |
| September, 2026 | $2.7834 | $2.4734 | $3.8403 | +81.92% |
| October, 2026 | $0.1364 | $0.0099 | $2.8166 | -91.08% |
| November, 2026 | $0.3194 | $0.0474 | $0.6662 | -79.12% |
| December, 2026 | $0.4857 | $0.2658 | $1.1357 | -68.25% |
TRACON Pharmaceuticals Inc Stock (TCON) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for TRACON Pharmaceuticals Inc (TCON) is $0.7278, with a high forecast of $1.3341 and a low forecast of $0.1214. This indicates an -52.43% decrease from the last price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4388 | $0.1988 | $0.8255 | -71.32% |
| February, 2027 | $0.6582 | $0.1214 | $0.6153 | -56.98% |
| March, 2027 | $0.3019 | $0.8017 | $0.5784 | -80.27% |
| April, 2027 | $0.7689 | $0.5486 | $0.6214 | -49.75% |
| May, 2027 | $0.3958 | $0.6472 | $0.6823 | -74.13% |
| June, 2027 | $0.6295 | $0.7393 | $0.526 | -58.85% |
| July, 2027 | $0.3265 | $0.3465 | $0.1574 | -78.66% |
| August, 2027 | $0.6934 | $0.3331 | $0.3934 | -54.68% |
| September, 2027 | $1.0272 | $0.9202 | $0.9672 | -32.87% |
| October, 2027 | $1.4541 | $1.1639 | $1.3341 | -4.96% |
| November, 2027 | $0.7511 | $0.8211 | $0.9809 | -50.91% |
| December, 2027 | $0.6448 | $0.8648 | $0.8413 | -57.86% |
TRACON Pharmaceuticals Inc Stock (TCON) Price Forecast for 2028
In 2028, TRACON Pharmaceuticals Inc (TCON) is projected to reach an average price of $0.9191, with a high projection of $1.5638 and a low estimate of $0.2744. This indicates an -39.93% fall from the last price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6218 | $0.6515 | $0.6115 | -59.36% |
| February, 2028 | $0.8887 | $0.7452 | $0.662 | -41.91% |
| March, 2028 | $0.9124 | $0.8922 | $0.8624 | -40.36% |
| April, 2028 | $0.9294 | $0.9992 | $0.9194 | -39.26% |
| May, 2028 | $1.0681 | $0.9561 | $1.0131 | -30.19% |
| June, 2028 | $0.6201 | $0.7032 | $0.7999 | -59.47% |
| July, 2028 | $0.597 | $0.6103 | $0.5935 | -60.98% |
| August, 2028 | $0.7707 | $0.6205 | $0.6614 | -49.63% |
| September, 2028 | $0.0877 | $0.2977 | $0.5875 | -94.27% |
| October, 2028 | $1.3746 | $0.2744 | $1.2546 | -10.15% |
| November, 2028 | $1.4104 | $1.4493 | $1.4149 | -7.82% |
| December, 2028 | $1.6843 | $1.4301 | $1.5638 | +10.09% |
TRACON Pharmaceuticals Inc Stock (TCON) Price Forecast for 2029
The 2029 price forecast for TRACON Pharmaceuticals Inc Stock (TCON) is $1.7096 on average, with a high prediction of $3.168 and a low estimate of $0.2511. This represents an +11.74% increase from the previous price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.6081 | $1.6288 | $1.6343 | +5.11% |
| February, 2029 | $1.6058 | $1.5695 | $1.5392 | +4.95% |
| March, 2029 | $1.549 | $1.5794 | $1.5727 | +1.24% |
| April, 2029 | $1.5579 | $1.6054 | $1.5792 | +1.82% |
| May, 2029 | $1.4533 | $1.5376 | $1.5617 | -5.01% |
| June, 2029 | $1.4281 | $1.456 | $1.4502 | -6.66% |
| July, 2029 | $1.4024 | $1.4076 | $1.4076 | -8.34% |
| August, 2029 | $1.3218 | $1.322 | $1.381 | -13.61% |
| September, 2029 | $1.2921 | $1.2915 | $1.299 | -15.55% |
| October, 2029 | $0.9353 | $1.1044 | $1.256 | -38.87% |
| November, 2029 | $0.6211 | $0.2511 | $2.0219 | -59.40% |
| December, 2029 | $3.474 | $0.3744 | $3.168 | +127.06% |
TRACON Pharmaceuticals Inc Stock (TCON) Price Forecast for 2030
TRACON Pharmaceuticals Inc Stock (TCON) is expected to reach an average price of $5.5768 in 2030, with a high forecast of $7.7586 and a low forecast of $3.395. This signifies an +264.50% surge from the last price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.0214 | $3.395 | $3.5354 | +162.84% |
| February, 2030 | $4.2213 | $3.6824 | $3.8863 | +175.90% |
| March, 2030 | $5.2533 | $4.7918 | $5.2243 | +243.35% |
| April, 2030 | $4.4172 | $5.0182 | $5.0967 | +188.71% |
| May, 2030 | $5.3156 | $4.8707 | $4.9926 | +247.43% |
| June, 2030 | $6.2785 | $5.9581 | $5.9135 | +310.36% |
| July, 2030 | $6.1159 | $5.7355 | $5.8659 | +299.73% |
| August, 2030 | $6.9598 | $6.2594 | $6.2899 | +354.89% |
| September, 2030 | $6.4138 | $7.0038 | $7.0368 | +319.20% |
| October, 2030 | $5.0628 | $5.2411 | $5.1377 | +230.90% |
| November, 2030 | $8.0251 | $5.4047 | $6.7752 | +424.52% |
| December, 2030 | $7.4091 | $7.5656 | $7.7586 | +384.25% |
4.27%
2.59%
Cap:
|
Volume (24h):